Malin Hultcrantz
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Malin Hultcrantz as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:24 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07105059 · A Study of Teclistamab and Mezigdomide in People With Multiple MyelomaMemorial Sloan Kettering Cancer Center · recruiting · Multiple Myeloma · principal investigator
- Ph1NCT05556798 · A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After TreatmentMemorial Sloan Kettering Cancer Center · active not recruiting · Multiple Myeloma · principal investigator
- Ph2NCT03767257 · A Study of Colesevelam for Lenalidomide-Associated DiarrheaMemorial Sloan Kettering Cancer Center · completed · Multiple Myeloma, Diarrhea · principal investigator
- Ph1NCT02831686 · A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With MyelomaMemorial Sloan Kettering Cancer Center · completed · Multiple Myeloma, Relapsed and/or Refractory Multiple Myeloma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:24 UTC. The ranking covers the 200 most relevant of 22 PubMed records, and a shared surname and initials can bring in a namesake. All 22 on PubMed
- GPRC5D-Targeted CAR T Cells for Myeloma.N Engl J Med · 2022385 citationsRCR 25.1
- Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial.Lancet Neurol · 2008300 citationsRCR 12.2
- 122 citationsRCR 7.1
- 105 citationsRCR 5.2
- Outcome of the bone-anchored hearing aid procedure without skin thinning: a prospective clinical trial.Otol Neurotol · 2011102 citationsRCR 5.9
- Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial.Lancet Haematol · 202189 citationsRCR 4.8
- Synkinesis in Bell's palsy in a randomised controlled trial.Clin Otolaryngol · 201745 citationsRCR 4.0
- A five-year follow-up on the osseointegration of bone-anchored hearing device implantation without tissue reduction.Otol Neurotol · 201439 citationsRCR 2.9
- The effect of prednisolone on sequelae in Bell's palsy.Arch Otolaryngol Head Neck Surg · 201238 citationsRCR 2.2
- Prediction of nonrecovery in Bell's palsy using Sunnybrook grading.Laryngoscope · 201230 citationsRCR 1.7